Brodalumab News
Brodalumab currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Brodalumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Kyntheum is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy.
- Evidence level: L5
- Predicted indications (20):
- strongyloidiasis (99.8%)
- eye disease (99.8%)
- vitamin deficiency disorder (99.8%)
- von Hippel anomaly (99.8%)
- isolated optic neuritis (99.8%)
- chronic relapsing inflammatory optic neuropathy (99.8%)
- recurrent idiopathic neuroretinitis (99.8%)
- optic perineuritis (99.8%)
- nodular episcleritis (99.8%)
- episcleritis periodica fugax (99.8%)
- accommodative spasm (99.8%)
- total internal ophthalmoplegia (99.8%)
- cycloplegia (99.8%)
- ocular hyperemia (99.8%)
- conjunctivochalasis (99.8%)
- dislocation of lens (99.8%)
- luxation of globe (99.8%)
- microcephaly microphthalmos blindness (99.8%)
- vitreous detachment (99.8%)
- microcornea-corectopia-macular hypoplasia syndrome (99.8%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.